See how company executives and directors have been buying or selling shares over the past 30 days. Insider trading activity can help investors better understand company leadership's actions.
0
0
$0.00
$0.00
Browse insider buying and selling activity reported to the SEC over the past year, including who traded, when they traded, and the value of each transaction.
No Insider Transactions found for ARGOS THERAPEUTICS INC
View older insider trading records reported to the SEC to research long-term buying and selling trends.
DATE INSIDER |
INSIDER | TYPE | SHARES | PRICE | SHARES PRICE VALUE |
|---|---|---|---|---|---|
Jan 09, 2018 Katz Richard D |
Katz Richard D
Vice President and CFO
|
Sell |
104,435 | $0.16 | 104,435 $0.16 $17,200 |
Jan 09, 2018 Harrelson Lori R. |
Harrelson Lori R.
Vice President of Finance
|
Sell |
64,329 | $0.16 | 64,329 $0.16 $10,595 |
Jan 09, 2018 Abbey Jeffrey D |
Abbey Jeffrey D
President, CEO
|
Sell |
124,987 | $0.16 | 124,987 $0.16 $20,573 |
Jan 09, 2018 Nicolette Charles A. |
Nicolette Charles A.
CSO and Vice President of R&D
|
Sell |
100,250 | $0.16 | 100,250 $0.16 $16,501 |
Jan 03, 2018 Katz Richard D |
Katz Richard D
Vice President and CFO
|
Sell |
101,228 | $0.16 | 101,228 $0.16 $16,541 |
Jan 03, 2018 Harrelson Lori R. |
Harrelson Lori R.
Vice President of Finance
|
Sell |
59,072 | $0.16 | 59,072 $0.16 $9,658 |
Jan 03, 2018 Abbey Jeffrey D |
Abbey Jeffrey D
President, CEO
|
Sell |
114,702 | $0.16 | 114,702 $0.16 $18,719 |
Jan 03, 2018 Abbey Jeffrey D |
Abbey Jeffrey D
President, CEO
|
Sell |
114,702 | $0.16 | 114,702 $0.16 $18,719 |
Jan 03, 2018 Nicolette Charles A. |
Nicolette Charles A.
CSO and Vice President of R&D
|
Sell |
92,001 | $0.16 | 92,001 $0.16 $15,061 |
TOP